tariffs
Reshoring medical device manufacturing to ensure supply chain stability in unstable times
U.S.-based medical device manufacturers are reshoring production to improve quality, protect IP, and avoid supply chain uncertainty. Learn how Velocity Group supports ISO 13485-certified, cleanroom-equipped, end-to-end manufacturing.
More in tariffs
Market trends: Cutting tool orders increased despite tariff challenges
March 2025 US cutting tool orders total $207.1 million, up 4.3% from February.
Navigating the tariff storm: Insights for tech leaders
New whitepaper explores the unpredictable tariff environment, revealing risks, ripple effects, and emerging opportunities across the global technology ecosystem.
Be proactive – stay ahead of tariffs and other economic and supply chain curveballs!
Learn how to boost your manufacturing company’s cash flow, improve EBIDTA, and more – even in uncertain times.
Tariff turmoil
Learn more about how current trade policies and tariffs on medical devices are shaking up U.S. medical device manufacturing.
AdvaMed statement on tariff announcement
Tariffs will hold back the U.S. medtech industry. It will have a negative impact on innovation, cost jobs, and increase overall costs to the health care system.
How Trump's tariffs could impact US companies
PwC’s US Tariff Industry Analysis notes that key sectors to be impacted include medical device, technology, automotive, aerospace, to name a few. In the article is a download for the full tax insight analysis.
Tariffs threaten small business growth, increase costs across industries
The impact of tariffs on small businesses – rising costs and uncertain futures.
Navigating through the tariffs in medical device manufacturing
Uncertainty in global trade policy is nothing new, but its impact on medtech manufacturing is becoming increasingly difficult to ignore.
Tariffs: Fine for thee, not for me
Trump's tariffs pose significant challenges to manufacturing – boosting inflation, increasing the cost of production, disrupting supply chains, diminishing U.S. competitiveness, creating compliance and regulatory challenges, impacting innovation, and reducing project margins.
